LBA2 DeFi: A phase III, randomized controlled trial of nirogacestat versus placebo for progressing desmoid tumors (DT)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Kasper, B; Ratan, R; Alcindor, T; Schoeffski, P; van der Graaf, WTA; Wilky, BA; Riedel, RF; Lim, A; Smith, LM; Moody, S; Attia, S; Chawla, SP; D'Amato, G; Federman, N; Van Tine, P; Van Tine, BA; Vincenzi, B; Kummar, S; Gounder, MM

Published Date

  • September 2022

Published In

Volume / Issue

  • 33 /

Start / End Page

  • S1435 - S1436

Published By

International Standard Serial Number (ISSN)

  • 0923-7534

Digital Object Identifier (DOI)

  • 10.1016/j.annonc.2022.08.075